glp-1 news 2025 october 9 Understanding GLP-1s and their dynamic marketplace and workplace trends GLP-1s for Weight Loss: What

Emerging evidence suggests that semaglutide and other drugs in the same class known as glucagon-like peptide receptor agonists (GLP1-RAs) may have benefits for other conditions

Male and female panels, fertility hormones, thyroid, cortisol

Dosing Phases, Titration & Cycling Unlike short recovery peptides, semaglutide is not run in on/off cycles. The documented protocol is a single continuous escalation to a maintenance dose that is then held, because the metabolic effect depends on sustained receptor engagement weight tends to return when the drug is stopped

[57] reported that 2-deoxyglucose (2-DG), a glycolytic inhibitor and a caloric restriction mimetic, suppressed the LPS-induced nuclear accumulation of PKM2 and the phosphorylation of STAT3